Sign in
4

Changes in Ownership

Insight Molecular Diagnostics Inc. Filed Acc 0001493152-20-000240

Previous 10% Owner sold 2,383,090 shares at $2.16 ($5,137,942)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lineage Cell Therapeutics, Inc. Previous 10% Owner 2020-01-02 Sale −2,383,090 $2.16 $5,137,942 6,041,154 D
Open-market sales · 2,383,090 sh · avg $2.16 · $5,137,942
Loading xslF345X03/ownership.xml…